Sabra Healthcare REIT (NASDAQ:SBRA – Free Report) had its price objective boosted by Robert W. Baird from $20.00 to $21.00 in a report published on Monday,Benzinga reports. The firm currently has a neutral rating on the real estate investment trust’s stock.
Several other equities research analysts have also recently weighed in on SBRA. Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Raymond James Financial raised shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. UBS Group set a $25.00 price target on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Finally, Cantor Fitzgerald boosted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $22.17.
Get Our Latest Analysis on SBRA
Sabra Healthcare REIT Trading Down 0.4%
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. During the same quarter last year, the business posted $0.38 earnings per share. The business’s quarterly revenue was up 24.7% compared to the same quarter last year. Analysts predict that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is presently 461.54%.
Hedge Funds Weigh In On Sabra Healthcare REIT
Institutional investors have recently modified their holdings of the stock. Amundi increased its stake in shares of Sabra Healthcare REIT by 8.1% in the 2nd quarter. Amundi now owns 197,364 shares of the real estate investment trust’s stock valued at $3,851,000 after acquiring an additional 14,744 shares during the last quarter. HighTower Advisors LLC boosted its stake in Sabra Healthcare REIT by 50.0% during the 2nd quarter. HighTower Advisors LLC now owns 48,594 shares of the real estate investment trust’s stock worth $948,000 after acquiring an additional 16,195 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Sabra Healthcare REIT during the 2nd quarter worth approximately $6,045,000. California State Teachers Retirement System grew its holdings in Sabra Healthcare REIT by 1,824.2% during the second quarter. California State Teachers Retirement System now owns 5,746,631 shares of the real estate investment trust’s stock valued at $112,117,000 after purchasing an additional 5,447,978 shares during the period. Finally, Readystate Asset Management LP acquired a new position in Sabra Healthcare REIT during the second quarter valued at approximately $1,400,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.
Sabra Healthcare REIT Company Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.
Recommended Stories
- Five stocks we like better than Sabra Healthcare REIT
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
